Scotia Capital’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $860K | Sell |
10,991
-1,146
| -9% | -$89.6K | ﹤0.01% | 555 |
|
|
2025
Q1 | $880K | Sell |
12,137
-2,962
| -20% | -$215K | ﹤0.01% | 536 |
|
|
2024
Q4 | $1.12M | Buy |
+15,099
| New | +$1.12M | 0.01% | 504 |
|
|
2024
Q3 | – | Sell |
-19,099
| Closed | -$1.76M | – | 853 |
|
|
2024
Q2 | $1.76M | Sell |
19,099
-554
| -3% | -$51.2K | 0.01% | 396 |
|
|
2024
Q1 | $1.88M | Sell |
19,653
-2,733
| -12% | -$261K | 0.01% | 382 |
|
|
2023
Q4 | $1.71M | Buy |
22,386
+905
| +4% | +$69K | 0.01% | 375 |
|
|
2023
Q3 | $1.49M | Sell |
21,481
-707
| -3% | -$49K | 0.01% | 381 |
|
|
2023
Q2 | $2.09M | Sell |
22,188
-1,016
| -4% | -$95.8K | 0.01% | 336 |
|
|
2023
Q1 | $1.92M | Buy |
23,204
+3,415
| +17% | +$283K | 0.01% | 355 |
|
|
2022
Q4 | $1.48M | Buy |
19,789
+8,884
| +81% | +$663K | 0.01% | 394 |
|
|
2022
Q3 | $901K | Buy |
10,905
+154
| +1% | +$12.7K | 0.01% | 467 |
|
|
2022
Q2 | $1.02M | Sell |
10,751
-11,173
| -51% | -$1.06M | 0.01% | 469 |
|
|
2022
Q1 | $2.58M | Sell |
21,924
-756
| -3% | -$89K | 0.02% | 351 |
|
|
2021
Q4 | $2.94M | Buy |
22,680
+1,749
| +8% | +$227K | 0.02% | 339 |
|
|
2021
Q3 | $2.37M | Sell |
20,931
-42
| -0.2% | -$4.76K | 0.02% | 362 |
|
|
2021
Q2 | $2.17M | Buy |
20,973
+328
| +2% | +$34K | 0.02% | 369 |
|
|
2021
Q1 | $1.73M | Buy |
20,645
+1,287
| +7% | +$108K | 0.01% | 372 |
|
|
2020
Q4 | $1.77M | Buy |
19,358
+766
| +4% | +$69.9K | 0.02% | 342 |
|
|
2020
Q3 | $1.48M | Buy |
+18,592
| New | +$1.48M | 0.02% | 334 |
|
|
2020
Q2 | – | Sell |
-17,130
| Closed | -$1.08M | – | 674 |
|
|
2020
Q1 | $1.08M | Buy |
17,130
+2,166
| +14% | +$136K | 0.02% | 324 |
|
|
2019
Q4 | $1.16M | Buy |
14,964
+8,022
| +116% | +$624K | 0.01% | 374 |
|
|
2019
Q3 | $509K | Buy |
+6,942
| New | +$509K | 0.01% | 513 |
|
|
2018
Q1 | – | Sell |
-20,730
| Closed | -$779K | – | 716 |
|
|
2017
Q4 | $779K | Buy |
20,730
+465
| +2% | +$17.5K | 0.01% | 435 |
|
|
2017
Q3 | $738K | Sell |
20,265
-750
| -4% | -$27.3K | 0.01% | 444 |
|
|
2017
Q2 | $828K | Sell |
21,015
-780
| -4% | -$30.7K | 0.01% | 389 |
|
|
2017
Q1 | $684K | Sell |
21,795
-2,049
| -9% | -$64.3K | 0.01% | 424 |
|
|
2016
Q4 | $745K | Buy |
23,844
+11,964
| +101% | +$374K | 0.01% | 387 |
|
|
2016
Q3 | $476K | Sell |
11,880
-444
| -4% | -$17.8K | 0.01% | 451 |
|
|
2016
Q2 | $410K | Buy |
+12,324
| New | +$410K | 0.01% | 445 |
|
|
2014
Q2 | – | Sell |
-32,526
| Closed | -$402K | – | 583 |
|
|
2014
Q1 | $402K | Sell |
32,526
-2,100
| -6% | -$26K | 0.01% | 435 |
|
|
2013
Q4 | $379K | Buy |
34,626
+12,210
| +54% | +$134K | 0.01% | 414 |
|
|
2013
Q3 | $260K | Buy |
22,416
+1,980
| +10% | +$23K | 0.01% | 426 |
|
|
2013
Q2 | $229K | Buy |
+20,436
| New | +$229K | 0.01% | 411 |
|